Showing results (271-280 of 282) with videos related to

Sort By:
Pageof 29
Advanced Materials (Deerfield Beach, Fla.)|March 11, 2014
Microfluidic-assisted self-assembly of complex dendritic polyethylene drug delivery nanocapsulesMohammad Mahdi Hasani-Sadrabadi, Vahid Karimkhani, Fatemeh Sadat Majedi, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Therapie|November 7, 1998
[Toxicology of reproduction: predictive value of experimental models. Round Table No 1 at Giens XIII]P Guittin, C Soubrié, E Autret, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Scientific Reports|June 5, 2020
Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalitiesTakuhiro Sonoyama, Lukas K J Stadler, Mingyan Zhu, et al.
Human Mutation|October 15, 2013
Exome sequencing identifies potential risk variants for Mendelian disorders at high prevalence in QatarJuan L Rodriguez-Flores, Khalid Fakhro, Neil R Hackett, et al.
Diabetes|August 24, 2019
Crucial Role of the SH2B1 PH Domain for the Control of Energy BalanceAnabel Flores, Lawrence S Argetsinger, Lukas K J Stadler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Pageof 29